How GLP-1 meds change eating habits
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have overweight or obesity (BMI over 25)
- You are about to start or have just started (within 2 weeks) a GLP-1 medication like Wegovy, Ozempic, or similar
- You are fluent in English
- You have not taken a GLP-1 or similar drug in the past
- You do not have a diagnosed cognitive or physical disability, dyslexia, or epilepsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how GLP-1 medications (like Ozempic or Wegovy) combined with behavioral coaching through Noom affect weight loss and metabolic health over 12 months. You may qualify if you're interested in weight loss and willing to commit to a program for a year.
This study looks at how GLP-1 medications (like semaglutide/Wegovy or tirzepatide/Mounjaro) change your sense of taste and eating habits while losing weight. If you are 18–60, have obesity, and have been taking one of these drugs for at least 12 weeks, you may qualify.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
This study tests a 4-month digital program to help people taking a GLP-1 medication (like Ozempic or Wegovy) make healthy lifestyle changes while they continue the drug. Participants will get guidance and wear a Fitbit to track activity.
This study looks at how GLP-1 medications (like Ozempic or Wegovy) affect the movement of food through your stomach and intestines. You may join if you are starting or recently stopped one of these medications and have type 2 diabetes or obesity.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.